Photocat successfully completes private placement of SEK 1.9 million

Photocat A/S (publ) has completed a private placement of 248,928 new shares to the management & founders (Mette Therkildsen, Michael Humle, Henrik Jensen and Theis Reenberg), CAPNOVA Invest Zealand and Scanventure. The private placement provides Photocat A/S with around SEK 1.9 million in new equity.

The Board of Directors in Photocat A/S has utilized authorization in the Company’s articles of association to complete a private placement without preferential rights for the current shareholders. The issue of 248,928 new shares has been completed at a price of SEK 7.5 pr. share with a nominal amount of DKK 1.00 each.

The placement increases Photocat’s share capital from DKK 3,000,000 to DKK 3,248,928. After the placement, the total number of shares in Photocat is 3,248,928. Pursuant to the Company’s articles of association the Board of Directors have no remaining authorization to issue further shares at fair market value without preferential rights for the shareholders.

With this issue Photocat has ensured sufficient capital to support the further development of the company, which will be to the benefit of all shareholders.

The private placement corresponds to a dilution of 7.7 percent of the shares in the Company after completion of this private placement.

For More Information, please contact:

Adam Sagedahl, Strategic Director, Photocat A/S                                                
Tel: +45 4275 9546                                                                            
e-mail: adam.sagedahl@photocat.net

Photocat A/S is obliged to publicize this information in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at CET 17:30 on August 28th 2018.

About Photocat

Photocat manufactures patented coating materials for both outdoor and indoor applications with the effect to degrade NOx and VOC´s when exposed to light. Both NOx and VOC’s are severely damaging to human health. Photocat’s patented technology is a very efficient and an economically viable alternative to many of the traditional technologies targeting NOx (e.g. bus catalysts, flue gas cleaning etc.). Photocat’s shares are listed on Nasdaq Stockholm, First North with the ticker symbol PCAT. The company’s Certified Advisor is Mangold Fondkommision AB, 08-50301550.